Disease · MONDO_0019065
Comparisons in its trials15
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 15 of 15
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Standard Dose Stem Cell Group vs High Dose Stem Cell Group: deaths from any cause | 0 of 35 | 0 of 40 | 75 | NCT00651937 | Trial comparisons |
| Standard Dose Stem Cell Group vs High Dose Stem Cell Group: serious adverse events | 1 of 35 | 0 of 40 | 75 | NCT00651937 | Trial comparisons |
| Amyloidosis vs Monoclonal Ig DepositionDisease (MIDD): Participants Evaluated for Toxicity | 19 of 19 | 1 of 1 | 20 | NCT01383759 | Trial comparisons |
| Amyloidosis vs Monoclonal Ig DepositionDisease (MIDD): deaths from any cause | 7 of 19 | 0 of 1 | 20 | NCT01383759 | Trial comparisons |
| Amyloidosis vs Monoclonal Ig DepositionDisease (MIDD): serious adverse events | 17 of 19 | 1 of 1 | 20 | NCT01383759 | Trial comparisons |
| Dose Level 0- Safety Population vs Dose Level 1- Safety Population: Time to Amyloidotic Organ Response Based on Reported Data. | 0 of 3 | 0 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0- Safety Population vs Dose Level 1- Safety Population: Number of Patients Progression-free at 6 Months Based on Reported Data. | 3 of 3 | 7 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0- Safety Population vs Dose Level 1- Safety Population: Number of Patients Experiencing Dose Delays Based on Reported Data. | 2 of 3 | 1 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0- Safety Population vs Dose Level 1- Safety Population: Compliance Profile of KTD Based on Reported Chemotherapy Compliance Data. | 1 of 3 | 5 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0- Safety Population vs Dose Level 1- Safety Population: Number of Patients Withdrawing From Treatment Based on Reported Data. | 0 of 3 | 0 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0- Safety Population vs Dose Level 1- Safety Population: Number of Participants Experiencing Grade 3 or 4 Toxicity as Assessed by CTCAE v4.0. | 2 of 3 | 3 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0 - Safety Population vs Dose Level 1 - Safety Population: deaths from any cause | 0 of 3 | 0 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0- Safety Population vs Dose Level 1- Safety Population: Number of Deaths at 6 Months Based on Reported Data. | 0 of 3 | 0 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0 - Safety Population vs Dose Level 1 - Safety Population: serious adverse events | 1 of 3 | 2 of 7 | 10 | NCT02545907 | Trial comparisons |
| Dose Level 0 vs Dose Level 1: Number of Participants With Dose-Limiting Toxicities as Assessed by Reported Data | 0 of 3 | 1 of 6 | 9 | NCT02545907 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0019065/comparisons